SightfileU.S. market data from official filings

CEL SCI Corp (CVM)

Name: CEL SCI Corp (CVM) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000725363 · EDGAR filings · Updated 2026-07-02

CEL SCI Corp (CVM) has reported institutional ownership of 8.8%, with 38 institutional managers holding positions valued at $2.40M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

8.8%

Institutional managers

Reported 13F value

$2.40M

Insider activity

16 trans.

$470.0K net buying

Data flags

2 active

from SEC filings

Latest updates

2026-07-02 — ARS filed
2026-07-02 — Proxy statement (DEF 14A) filed
2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-06-16 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, CEL SCI Corp has 38 institutional holders and institutional ownership of 8.8%.

Insider activity

Insiders reported 16 transactions (4 buys, 0 sells) across 4 reporting insiders, with a net reported value of $470.0K.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-15 (recurring since 2020-02-10) — source filing. The authoritative details are those stated in the filing itself.

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2020-12-29 (recurring since 2020-12-29) — source filing. The authoritative details are those stated in the filing itself.

Related companies

ONCOLYTICS BIOTECH INC COM NEW (ONCY) · Bolt Biotherapeutics Inc (BOLT) · BIOATLA INC (BCAB) · LONGEVERON INC (LGVN) · MIRA PHARMACEUTICALS INC COM (MIRA) · IMPACT BIOMEDICAL INC (IBO)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-02.